(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LENTIHERO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LENTIHERO

ST13

US500000097604122

Class

1, 5

Filing

97604122

Registration

7781714

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

05/07/2025

Trademark type

Word

Nice classes

1, 5

Filing date

09/23/2022

Registration date

05/06/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/06/2025

Last transaction

05/07/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

99

Owner location

Comberton, Cambridge, GB

Examiner

KLUWE, CHERYL

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

ASTREA UK SERVICES LIMITED

Representatives

Ben Natter HAUG PARTNERS, LLP

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Polymeric nanofiber filtering compositions for viral particle purificationother than for medical or veterinary purposes; polymeric nanofiber filtering materials for virus-like particle purificationother than for medical or veterinary purposes; polymeric nanofiber filtering compositions for viral vector purificationother than for medical or veterinary purposes; filtering materials in the nature of unprocessed plasticsceramic particlesfor viral particlevirus-like particle and viral vector purification of chemical and biological substancesother than for medical or veterinary purposes; chromatographic media for purification of viral particlesvirus-like particles and viral vectors other than for medical or veterinary purposes; filtering media consisting of chemicals and biologicals for chromatographic purification of substances comprising of chemicals and biologicalsother than for medical or veterinary purposes; chemical and biological absorbents and adsorbents for recovery of viral particles and virus-like particles for viral vector developmentother than for medical or veterinary purposes; chemical and biological purifying agents for chromatographic purification of chemical and biological preparationsother than for medical or veterinary purposes; chemicals and biologicals for use in bioseparation for viral particlevirus-like particle and viral vector purificationother than for medical or veterinary purposes; chemicals and biologicals for use in filtering for viral particlevirus-like particle and viral vector purificationother than for medical or veterinary purposes; chemical and biological substances for use in separation for viral particlevirus-like particle and viral vector purificationother than for medical or veterinary purposes; fibres of inorganic polymeric material for separation purposes for viral particlevirus-like particle and viral vector purificationother than for medical or veterinary purposes; fibres of organic polymeric material for separation purposes for viral particlevirus-like particle and viral vector purificationother than for medical or veterinary purposes; raw proteins for scientific and medical research; proteins for scientific and industrial use; enzymes for scientific and industrial usereagents for scientific and research use other than for medical use; ligands for scientific and research use; biochemicalsantibodies and antibody fragments for in vitro scientific or research use

Class 5

Proteins for medical diagnostic purposes; enzymes for medical and medical diagnostic use; viral particlesvirus-like particles and viral vectors for medical use; proteinsnamely polypeptides for medical use; medical and clinical diagnostic reagents; insulin and insulin analogues; Polymeric nanofiber filtering compositions for viral particlevirus-like particle and viral vector purificationfor medical or veterinary purposes; polymeric nanofiber filtering materials for viral particlevirus-like particle and viral vector purificationfor medical or veterinary purposes; filtering materials in the nature of unprocessed plasticsceramic particlesfor viral particle virus-like particle and viral vector purification of chemical and biological substancesfor medical or veterinary purposes; chromatographic media for purification of viral particlesvirus-like particles and viral vectors for medical or veterinary purposes; filtering media consisting of chemicals and biologicals for chromatographic purification of substances comprising of chemicals and biologicalsfor medical or veterinary purposes; chemical and biological absorbents and adsorbents for recovery of viral particles and viral -like particles for viral vector developmentfor medical or veterinary purposes; chemical and biological purifying agents for chromatographic purification of chemical and biological preparationsfor medical or veterinary purposes; chemicals and biologicals for use in bioseparation for viral particlevirus-like particle and viral vector purificationfor medical or veterinary purposes; chemicals and biologicals for use in filtering for viral particlevirus-like particle and viral vector purificationfor medical or veterinary purposes; chemical and biological substances for use in separation for viral particle virus-like particle and viral vector purificationfor medical or veterinary purposes; fibres of inorganic polymeric material for separation purposes for viral particle virus-like particle and viral vector purificationfor medical or veterinary purposes; fibres of organic polymeric material for separation purposes for viral particlevirus-like particle purificationfor medical or veterinary purposes

Publications

History of USPTO decisions and trademark events.

35 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/06/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

05/06/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/18/2025

PUBO

PUBLISHED FOR OPPOSITION

03/18/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/12/2025

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/24/2025

EXPT

EXPARTE APPEAL TERMINATED

02/21/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/21/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/27/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/27/2025

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

01/24/2025

EXPI

EX PARTE APPEAL-INSTITUTED

01/24/2025

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

01/24/2025

EXAF

EXPARTE APPEAL RECEIVED AT TTAB

01/24/2025

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

10/22/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

10/22/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

07/26/2024

GNFR

FINAL REFUSAL E-MAILED

07/26/2024

CNFR

FINAL REFUSAL WRITTEN

07/26/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/08/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/08/2024

ALIE

ASSIGNED TO LIE

03/07/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

10/18/2023

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

10/16/2023

GNSL

LETTER OF SUSPENSION E-MAILED

10/16/2023

CNSL

SUSPENSION LETTER WRITTEN

10/16/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/13/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/13/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/13/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/14/2023

GNRT

NON-FINAL ACTION E-MAILED

07/14/2023

CNRT

NON-FINAL ACTION WRITTEN

07/14/2023

DOCK

ASSIGNED TO EXAMINER

06/24/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/11/2022

NWAP

NEW APPLICATION ENTERED

09/27/2022

Continuous trademark protection

Get notified about every new filing that threatens LENTIHERO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.